Clinical Trials Directory

Trials / Completed

CompletedNCT03169595

Epithelioid Hemangioma of Bone And Soft Tissue

Epithelioid Hemangioma of Bone And Soft Tissue: a Benign Tumor With Metastatic Potential

Status
Completed
Phase
Study type
Observational
Enrollment
70 (actual)
Sponsor
Istituto Ortopedico Rizzoli · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The controversy surrounding epithelioid hemangioma diagnosis stems from its somewhat aggressive clinical characteristics, including multifocal presentation and occasional lymph node involvement. The investigators reviewed the clinicopathologic and radiologic characteristics of bone and soft tissue epithelioid hemangioma in patients treated at our institution with available tissue for molecular testing. The hypothesis is that epithelioid hemangioma may present with multifocal involvement and rare loco-regional lymph node metastasis, but it remains a benign tumor with excellent prognosis.

Detailed description

The investigators retrospectively reviewed patients treated for epithelioid hemangioma of the bone and soft tissue in a single insitution. The purpose of this study is to evaluate the pathological, clinical, and radiological characteristics of epithelioid hemangioma arising within bone and soft tissue, in the first cohort of cases where the definitive diagnosis is supplemented by molecular techniques. The hypothesis is that the improved knowledge regarding this rare entity can more definitively elucidate the benign biology of epithelioid hemangioma.

Conditions

Interventions

TypeNameDescription
PROCEDURESurgeryPatients affected by epithelioid hemangioma treated with surgery

Timeline

Start date
2015-10-07
Primary completion
2017-05-17
Completion
2017-05-17
First posted
2017-05-30
Last updated
2017-05-30

Source: ClinicalTrials.gov record NCT03169595. Inclusion in this directory is not an endorsement.